Rate differences are an important effect measure in biostatistics and provide an alternative perspective to rate ratios. When the data are event counts observed during an exposure period, adjusted rate differences may be estimated using an identity-link Poisson generalised linear model, also known as additive Poisson regression. A problem with this approach is that the assumption of equality of mean and variance rarely holds in real data, which often show overdispersion. An additive negative binomial model is the natural alternative to account for this, however, standard model-fitting methods are often unable to cope with the constrained parameter space arising from the non-negativity restrictions of the additive model. In this paper, we propose a novel solution to this problem using a variant of the ECME algorithm. Our method provides a reliable way to fit an additive negative binomial regression model and also permits flexible generalisations using semi-parametric regression functions. We illustrate the method using a placebo-controlled clinical trial of fenofibrate treatment in patients with type II diabetes, where the outcome is the number of laser therapy courses administered to treat diabetic retinopathy. An R package is available that implements the proposed method.
Introduction
In many biostatistical contexts we observe an outcome that counts the number of times an event of interest occurred and often these counts are observed over differing units of exposure, such as differing time periods of follow-up. When a collection of covariates is also available, such data allow us to build a regression model quantifying the effects of the covariates on the rate at which events occur. In this context, the parameters in an additive regression M. W. Donoghoe and I. C. Marschner Statistics in Medicine overdispersion. Section 2 will outline the additive model that we will use based on the negative binomial distribution, and then Section 3 will describe how a variant of the Expectation-Conditional Maximisation-Either (ECME) algorithm can be used to reliably fit this model. We will then extend this in Section 4 to allow additional flexibility through smooth semi-parametric regression functions. A detailed illustrative application of the methods will then be provided in Section 5, using data from a large clinical trial in type II diabetics where the outcome is the number of laser therapy courses administered to treat diabetic retinopathy.
Additive negative binomial regression
The negative binomial distribution can be derived in several ways [16] , but in this context we motivate its use by introducing multiplicative Gamma-distributed errors into the Poisson model. We begin by assuming that the number of events Y i for individual i (i = 1, . . . , n) is distributed as
Here, N i is the fixed exposure over which Y i is observed, such that λ i represents the event rate per unit of exposure for individual i. Typically, N i will correspond to a fixed time period of observation for individual i, so that λ i is the event rate per unit of time, although other types of exposure are also possible. When modelling count data rather than rates, we can set N i = 1 for all i so that λ i is the expected count.
Under an additive regression model, the event rate is a linear function of the covariate vector x i and its associated parameter vector θ * , which we denote by
This is an identity-link Poisson GLM in which component j of θ * is the adjusted rate difference per unit change in component j of x i . A number of authors have discussed methods for fitting this model to obtain adjusted rate differences; see for example [2] and [7, pp. 152-157] . This model is a natural alternative to the multiplicative Poisson model with log link function, where the (exponentiated) parameters are adjusted rate ratios.
The Poisson model has the restrictive assumption that Var(Y i ) = E(Y i ), which is frequently violated in the direction of overdispersion, Var(Y i ) > E(Y i ). A natural way to accommodate this overdispersion is to adopt a more general mean-variance relationship, Var(Y i ) = σ 2 E(Y i ), for σ 2 > 1. For notational convenience we will rewrite this relationship in the equivalent form Var(Y i ) = (1 + φ)E(Y i ), for φ > 0. Then the desired mean-variance relationship can be achieved by generalising the Poisson model such that the mean is perturbed by multiplicative errors,
where η i is a random variable with E(η i ) = 1 and Var(η i ) = φ/(N i λ i ). This can be confirmed by a straightforward application of the law of total variance.
One possible cause of such overdispersion is unobserved heterogeneity in which some individuals are more eventprone than others due to factors that are not captured by the observed covariates. Whatever the cause of the overdispersion, λ i retains its interpretation as an event rate, and θ * its interpretation as a vector of adjusted rate differences, averaged over the population.
Specification of the model is completed by assuming a distribution for η i . A commonly used approach is to assume that η i is Gamma-distributed, which dates back to Greenwood and Yule [17] . This results in a negative It should be noted that other types of negative binomial models are also possible. In particular, if η i is assumed to be Gamma-distributed with constant variance φ, the resulting negative binomial distribution has a quadratic mean-variance relationship, Var(Y i ) = E(Y i )(1 + φE(Y i )). This model is referred to as NegBin II by Cameron and Trivedi [18] and various other comparative discussions of the two models have been provided; see for example [7] .
One advantage that is sometimes claimed for the NegBin II model is that, unlike NegBin I, when φ is fixed it is in the exponential family and therefore falls within the GLM framework. Nonetheless, this does not invalidate the use of the NegBin I distribution with an additive model for its mean. Indeed, in Section 5 we will present a motivating application in which our additive NegBin I approach is more appropriate, and this model will be our main focus in this paper. However, comparison with the additive NegBin II model will also be considered.
Expressing our model in terms of the usual negative binomial parameters leads to
where
with θ = θ * /φ and p = φ/(1 + φ). By finding the MLEsθ andp of this marginal negative binomial distribution, we can transform them back to obtain the MLEs of the coefficient of overdispersionφ and the adjusted rate differenceŝ
However, in practice the additive structure for r i (θ) leads to substantial model-fitting challenges stemming from the constraint r i (θ) ≥ 0. Indeed, as discussed in Section 6, there is no standard commercial software package that fits this model. In the next section we will describe how the additive structure combined with the fact that p is constant across individuals allows us to use the convolution properties of the negative binomial distribution to construct an underlying latent outcome model. This will then allow us to implement the ECME algorithm [19] , which provides a stable approach to model fitting.
Model fitting
In this section we describe how the additive negative binomial model can be reliably fitted using a variant of the ECME algorithm. To do this, we need to first describe the constrained parameter space and a latent outcome model that will be used as the complete-data model in an ECME algorithm. We then describe a variant of the ECME algorithm based on the combinatorial EM algorithm of Marschner [20] .
Parameter space
In describing the model-fitting procedure, it is helpful to keep the categorical and continuous covariates separate.
We will examine a model that includes A categorical covariates, u i1 , . 
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Thus the additive model is
which for simplicity we can express in the form equivalent to (1)
where θ j is the j th component of the parameter vector θ and we have defined the covariate vector for individual i 
for a covariate space X , which consists of all possible combinations of the levels of the categorical covariates and any value of the continuous covariates within their observed ranges
Note that the parameter space (4) does not place any restrictions on the individual components of the parameter vector θ, but we will introduce such restrictions in defining the latent outcome model.
Latent outcome model
In order to define a complete-data model for the ECME algorithm, we begin by considering a particular t = (t 1 , . . . , t A+B ), giving the reference level for each of the A + B covariates. For each categorical covariate a = 1, . . . , A, we choose t a ∈ {1, . . . , k a } and set α a (t a ) = 0. For each of the continuous covariates b = 1, . . . , B, the reference level is either the minimum or maximum observed value. That is,
for a choice of ς b ∈ {0, 1}. For a particular ς b , we define the shifted covariate v
, which will be non-negative for all i, and (3) can be equivalently written as
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For a particular choice of t, the complete-data model consists of J independent latent negative binomial random variables with common p underlying the observed Y i . That is,
. Because the sum of independent negative binomial random variables with common p is itself negative binomial, the complete-data model is equivalent to the observed-data model, with the additional restriction that the r ij (θ ′ ) parameter of each of the latent variable distributions must be non-negative. As each x ′ ij is defined to be nonnegative for all i and j, this natural restriction imposed by the complete-data model for a given t is effectively a non-negativity constraint on each of the components of θ ′ .
From (5) it is clear that for any choice of the reference level vector t, Λ(t, θ) = α ′ 0 , and the non-negativity constraints on the transformed parameters ensure that the fitted value for any other transformed covariate vector will be larger than this. Thus, the parameter space related to the complete-data model for a particular choice of t is Θ(t) × Φ, where
There are a k a × 2 B possible choices for the reference level vector t, which define a family of complete-data models. Importantly, for any θ ∈ Θ, the smallest fitted value must correspond to one of these possible choices of t. Hence, if we can find the constrained MLE associated with each of the complete-data models, the MLE for the observed-data model is simply the constrained MLE that attains the highest likelihood. This means that the MLE can be found by cycling through each of the possible choices of t, which constitutes an implementation of the combinatorial EM algorithm described by Marschner [20] . A useful feature of this approach is that it is straightforward to consider a parameter space in which a particular coefficient β b associated with a continuous covariate is constrained to be non-negative. This can be achieved by considering only the reference level vectors in which ς b = 0. Likewise, a non-positivity constraint can be imposed by considering only the reference level vectors in which ς b = 1. We will take advantage of this feature to include semi-parametric terms in our model, described in Section 4.
ECME algorithm
We find the MLE for a particular complete-data model by using the ECME algorithm described by Liu and Rubin [19] . In the ECME algorithm, the M-step of the EM algorithm [21] is replaced by a series of conditional maximisation (CM) steps, which act on a subset of the unknown parameters while keeping the others fixed at their current estimates. It differs from the ECM algorithm [22] in that some of the CM-steps can be designed to maximise the observed-data log-likelihood rather than the expected complete-data log-likelihood from the E-step. In order to ensure that the likelihood increases monotonically, Meng and Van Dyk [23] noted that the CM-steps maximising the observed-data log-likelihood must be performed after all steps that maximise the expected complete-data log-likelihood at each iteration.
After removing terms that do not depend on θ or p, the observed-data log-likelihood for the additive negative binomial model is
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and the complete-data log-likelihood for a chosen t has a similar form:
Given a set of starting parameter estimatesθ
, the E-step at the (c + 1) th iteration requires calculation
for which we use the property that the conditional distribution of negative binomial random variables with common p given their sum is beta-binomial [24] . That is,
, for y = 0, . . . , Y i , where B(·, ·) denotes the Beta function.
The first CM-step involves conditional maximisation of Q with respect to θ ′ , holding p constant at its current estimatep (c) . To do this, for each θ ′ j we must find the non-negative root of the derivative
This does not have an explicit solution, but we can exploit the property of the digamma function
in order to find an upper bound for the root
.
This allows the straightforward use of an omnibus root-finding routine, such as uniroot in R, to find the root in
In the second CM-step, we keep the additive partθ ′ (c+1) fixed at its current estimate, and update the estimate for p by maximising the observed-data log-likelihood, givinĝ
If our starting estimates are within the parameter space for a given complete-data model, the updated estimates at each iteration are guaranteed to remain within the parameter space, and the likelihood will increase until it converges to its maximum value within the restricted parameter space Θ(t).
This process is repeated for each possible choice of the reference vector t in order to find the global maximum, which is the constrained MLE with the highest likelihood. However, there are some situations in which we can stop early, having only searched a subset of the restricted parameter spaces [20] . In particular, if we find a stationary Statistics in Medicine M. W. Donoghoe and I. C. Marschner point in the interior of the parameter space Θ(t), we can be sure that it is the overall MLE.
Finally, after finding the overall MLE (θ ′ ,p), we can use the inverse of (6) to obtain the unshifted intercept and linear slope parameters, and then (2) to calculate the estimated coefficient of overdispersionφ, and the estimated rate difference parametersθ
For categorical covariates,α * a (u) is the rate difference associated with level u compared to the reference level t a , adjusted for the other A + B − 1 covariates. For continuous covariates,β * b is the adjusted rate difference associated with a one-unit increase in the b th continuous covariate.
Variance estimation
If our distributional assumption and mean model are correct, the MLE resulting from this method will be consistent, with an asymptotic multivariate normal distribution. We can obtain an estimate of the covariance matrix for the parameter estimates (θ * ,φ) by using the inverse of the observed information matrix, evaluated at the MLE. The relevant formulae are given in Section A of the supplementary materials available with the online version of this article.
However, asymptotic normality of the MLE may be questionable if the estimate is on or close to the boundary of the parameter space. In this case, confidence intervals for parameter estimates may be obtained by using a resampling method such as the bootstrap. The stability of our fitting method ensures that the MLE can be obtained in every resampled dataset, and so there will be no bias caused by non-convergence in some samples.
Semi-parametric model
In some situations it may be desirable to relax the linearity restriction on the effect of continuous covariates on the expected count or rate, and instead adjust for these covariates semi-parametrically. To allow this, we extend (3) to include C additional unspecified functions, so
As demonstrated by Donoghoe and Marschner [25] for the additive Poisson model, it is possible to incorporate the estimation of the unknown functions f c into the additive negative binomial model by using B-spline basis functions. This allows us to retain the stability of our estimation method, while still ensuring that the fitted means are non-negative. The approach relies on the fact that it is straightforward to impose non-negativity constraints on any of the parameters associated with continuous covariates. This is easy to do for the additive negative binomial model also, as discussed in Section 3.2. We now describe the B-spline model.
B-spline model
For notational convenience, in this subsection we will first consider the case of C = 1 and drop the subscript c from the unspecified function f c . We parameterise these regression functions using the B-spline model
. . , D} are B-spline basis functions [26] . Let τ be a set of D + κ knots on which the B-spline basis is defined, where κ − 1 is the desired degree of the smooth curve and D − κ of the knots are distinct turning points in the interior of the range of the continuous M. W. Donoghoe and I. C. Marschner
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covariate. Then the above model means that f is restricted to belong to B(τ ), the function space defined by the B-spline basis on τ . For simplicity, here we use κ = 3 and choose the D − 3 turning points to be evenly spaced quantiles of the observed {w i }, but these methods will work with any choice of κ and knot vector. We allow the level of smoothness to vary by fitting models with different numbers of turning points and choosing the one with the smallest AIC [12] . Other suitable model selection criteria can also be used, such as the small-sample version, AIC c [13] .
Each basis function B d is positive in (τ d , τ d+3 ) and zero elsewhere, meaning that if all of the γ d coefficients are non-negative, the resulting f will also be strictly non-negative. Furthermore, the B-spline bases are normalised such that D d=1 B d (w) = 1 for all w, so we must include an identifiability constraint on the coefficients of each curve. We begin by choosing a reference level t A+B+1 ∈ {1, . . . , D}, and impose an identifiability constraint by setting γ tA+B+1 = 0. The remaining coefficients can be estimated by treating the basis function values B d (w i ) as continuous covariates in the ECME algorithm, restricting their associated parameters to be non-negative. The resulting f will belong to B + (τ ; t A+B+1 ), which denotes the subspace of strictly non-negative curves in B(τ ) that have their shape constrained by the choice of t A+B+1 . We repeat this for all D possible choices of t A+B+1 , and the estimate with the highest likelihood is the MLE for the semi-parametric model.
Extension to C > 1 is straightforward: for each c = 1, . . . , C, we choose a reference level t A+B+c ∈ {1, . . . , D c }, set γ ctA+B+c = 0 and use the ECME algorithm to find the MLE, constraining the remaining B-spline coefficients to be non-negative. To find the global maximum, we repeat this for all C c=1 D c possible choices of these reference levels.
Monotonicity restriction
This approach also allows us to impose a monotonicity restriction on any of the smooth curves. A sufficient condition for the monotonicity of f is that coefficients of the B-spline basis functions are themselves strictly non-decreasing, that is γ 1 ≤ · · · ≤ γ D [27] . If we set γ 1 = 0 and introduce parameters δ 2 , . . . , δ D that represent the increments between successive coefficients, so
an equivalent condition is to require these increments to be non-negative.
Under this parameterisation,
so a monotonicity restriction can be applied simply by treating the partial sums of B-spline bases in (7) as continuous covariates, and constraining their associated parameters to be non-negative in the CEM algorithm. Because we only need to consider one parameterisation for each monotonic regression function, extension to C > 1 is trivial, and in fact the inclusion of additional semi-parametric monotonic covariates does not require additional applications of the ECME algorithm.
Application
The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study was a double-blind randomised clinical trial examining the effect of fenofibrate treatment on cardiovascular risk in 9795 participants with type II diabetes, aged between 50-75 years over a median follow-up time of 5 years [28] . A pre-specified secondary endpoint of the study was laser photocoagulation treatment for diabetic retinopathy, a microvascular complication of diabetes. Laser
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M. W. Donoghoe and I. C. Marschner therapy is used to slow or prevent vision loss caused by retinopathy, but is associated with visual field reduction and other side-effects [29] , so reducing the need for its use would be a positive outcome.
The vast majority of patients (96%) did not undergo laser therapy during the follow-up period, but individuals could have multiple courses of laser therapy, and we wish to estimate the effect of fenofibrate treatment on the number of laser therapy courses administered per 5 patient-years. In the primary analysis of these data [30] , a Poisson GLM with a log link function was used to estimate a rate ratio (RR) for the treatment effect. The overdispersion apparent under the Poisson model was accounted for by rescaling the estimated standard errors.
There The rate ratio estimates from these multiplicative models can be applied to the observed mean rates of laser therapy in the placebo group for those with and without known prior retinopathy to obtain estimates of the absolute rate reduction, and hence the expected number of laser therapy courses that may be avoided, by administering fenofibrate in these cohorts. Alternatively, by using an additive model we are able to directly estimate these absolute rate differences and their confidence intervals. The model will also allow us to adjust for individuals' duration of diabetes prior to study entry, which is strongly associated with the risk of retinopathy, and confounded with prior retinopathy status.
Assuming no interaction between treatment and known prior retinopathy, we estimated the effect of fenofibrate, first unadjusted for any covariates, then adjusted for baseline retinopathy, in an additive NegBin I model. The results are shown in Figure 1 as rate differences per 5 patient-years, along with their 95% confidence intervals.
Diabetes duration up to 20 years was then entered into the model as a flexible smooth term with a maximum of 5 internal knots. The inclusion of diabetes duration substantially improved the model fit as measured by the AIC (3853.4 with diabetes duration compared to 4014.3 without), and led to a noticeable reduction in the magnitude of the treatment effect estimate.
In order to obtain an estimate of the rate difference for fenofibrate separately in patients with and without known prior retinopathy, the model must include an interaction between treatment allocation and retinopathy status. The estimates from this model, with and without adjustment for diabetes duration, are also shown in Figure 1 . As expected from the analysis that showed no interaction on a multiplicative scale, the common relative effect of treatment is manifested in a smaller absolute rate difference for individuals at low risk, that is those without known prior retinopathy, compared to those at high risk. After adjustment for diabetes duration, this interaction is marginally significant (p = 0.044).
Under this model, the effect of diabetes duration on the rate of laser treatment is assumed to be the same for patients with and without known prior retinopathy. The estimated effect is shown in Figure 2 , with a 95% confidence interval obtained using the information matrix standard errors. This effect of increasing diabetes duration was allowed to be non-monotonic, and the estimate shows a small reduction in rate just prior to 20 years, which may be due to sampling error. The estimated effect of diabetes duration under a monotonicity constraint is also shown in Figure 2 
null [31] , is 1476.9. Accounting for overdispersion by using a distributional model allows us to estimate the number of patients in our sample expected to undergo a certain number of laser therapy courses, and these are shown in Figure 3 along with the observed histogram. The additive Poisson model substantially underestimates the number of patients who would not undergo any laser therapy, overestimates the number receiving a single course, and underestimates the number receiving 3 or more courses. In contrast, the negative binomial models capture the large proportion of zeros well: when we considered models that account for zero-inflation, these converged to the uninflated form. Both additive and multiplicative NegBin I models appear to fit the observed counts well, including in the tail of the distribution. The Chi-squared statistic for the observed versus expected counts shown in Figure 3 Figure 4 ) also suggests that a linear mean-variance relationship is more appropriate for these data.
As an extension, we considered the possibility that the effect of increasing diabetes duration may differ between patients with and without known prior retinopathy. We fitted a similar additive NegBin I model, with a monotonicity constraint but without the assumption of a common effect, and the expected rates under each model are shown in Figure 5 . The model that allowed different diabetes duration curves had superior fit in terms of AIC (3842.7 versus 3852.8), and shows a dramatic increase in the expected rate between 5 and 15 years of diabetes duration for patients with known prior retinopathy. As can be seen by examining the vertical distance between the pairs of lines in each case however, the estimated treatment effect is virtually identical under both models.
Discussion
We have described a stable method for finding the MLE in additive negative binomial regression, which allows for estimation of adjusted rate differences in the presence of overdispersion. It also allows for smooth semi-parametric regression using B-splines, with optional monotonicity constraints on these curves. The method respects the natural non-negativity restriction on the fitted means, which can cause issues for approaches that employ standard gradientbased algorithms such as Newton-Raphson.
Section B of the supplementary materials available online gives a detailed summary of existing software that can potentially fit models for estimating adjusted rate differences in the presence of overdispersion. At present, the gamlss package in R [9] is the only other available implementation of a method for fitting additive NegBin Archive Network (CRAN). Currently the package implements a basic version of the method, searching every possible constrained parameter space consecutively. We plan that future releases will focus on optimising the computational efficiency using techniques to reduce the number of ECME algorithms that need to be run, such as those discussed by Marschner [20] , and by taking advantage of the independent nature of the multiple ECME algorithms using parallel implementation on a multi-core processor.
The additive NegBin I model that we consider in this paper has a linear relationship between the conditional mean and variance, distinguishing it from the additive NegBin II model, which has a quadratic relationship. Both of these are nested in the NegBin-p model [18] , which could be used to test which is more appropriate, but there are no existing methods for fitting this model with an additive mean. Alternatively, a scatterplot similar to that used by Armitage [33] or Figure 4 can help to distinguish between NegBin I and NegBin II. Other forms of overdispersion could be investigated using models such as the generalised Poisson [34] and Poisson-inverse Gaussian [35] .
Both overdispersion and zero-inflation may be observed in the same data as a result of the data generating process. A possible extension of our method is the inclusion of zero-inflation by introducing a latent Bernoulli random variable into the complete-data model associated with the CEM algorithm. By utilising the methods of Marschner and Gillett [36] and Donoghoe and Marschner Rate difference (per 5 patient−years) Figure 1 . Estimated effect of fenofibrate on the rate of laser therapy in the FIELD study from additive negative binomial models, unadjusted and adjusted for prior retinopathy status and diabetes duration. p(Int) denotes the p-value for testing an interaction between treatment and retinopathy history. Number of laser therapy events Number of individuals Laser therapy rate (per 5 patient−years) Figure 5 . Fitted rates of laser therapy per 5 patient-years by baseline diabetes duration in the FIELD study under an additive negative binomial model. In (A), the effect of diabetes duration was restricted to be the same for all patients, whereas in (B) it was allowed to differ for those with and without known prior retinopathy.
